Posted Aug 28, 2026

Senior Product Manager, US Commercial

Apply Now
Reporting to the Executive Director, Global Marketing, the Senior Product Manager, US Commercial plays a key role in tactical implementation of the potential launch of MOLBREEVITM (molgramostim inhalation solution), an investigational therapy for treating autoimmune pulmonary alveolar proteinosis (aPAP).  This role is critical in guiding the development and implementation of the US Brand Plan to ensure a successful market introduction. The position focuses on executing innovative and impactful initiatives for healthcare professionals (HCPs) and patients, managing the marketing mix, and collaborating cross-functionally with various departments to meet brand and company objectives.  Responsibilities Under the guidance of the Executive Director, Global Marketing, assist in developing the strategic US brand plan for MOLBREEVI, including market opportunity identification, market-shaping, positioning, messaging, campaign development, and segmentation  Optimize Disease State Awareness campaigns to increase market impact  Collaborate with opinion leaders and cross-functional teams to develop and gain approval for core promotional programs and tactics, ensuring launch readiness  Lead commercial execution at key conferences, society meetings, and educational initiatives  Contribute to the design and development of exceptional patient services and specialty pharmacy programs Create and implement marketing and sales training materials  Develop and execute print, digital, and social media tactics for both HCPs and patients  Serve as a brand expert with deep knowledge of disease state, treatment landscape, patient journey, and market trends  Oversee partners to ensure strategic alignment and timely, budget-compliant execution of programs and tactics  Ensure all Medical Legal Regulatory (MLR) review processes are followed, and all programs are compliant with legal guidance and corporate policies  Serve as the primary coordinator for Medical, Legal, and Regulatory (MLR) review, managing workflows and timelines while partnering with cross-functional teams to ensure all materials and programs meet legal, regulatory, and corporate compliance standards. Manage funds and resources efficiently and with an entrepreneurial approach  Other duties and projects as assigned. Required Qualifications Bachelor’s degree required  5+ years pharma/biotech industry experience required  HCP and/or patient marketing experience required  Commercial launch experience required; rare disease commercial launch experience strongly preferred  Demonstrated experience in driving performance and fostering collaboration  Ability to embrace teamwork and project management within a collaborative environment Demonstrated analytical skills with regards to market research and key business insights  Strong interpersonal and communication skills and the ability to effectively drive performance  Excellent written and verbal communication skills in English  Ability to move nimbly between strategic thinking and tactical details to execute with excellence  Ability to thrive in a fast-paced, entrepreneurial environment.  Experience in managing external partners (e.g., consultants, vendors, agencies, etc.)  Proven ability to develop exceptional relationships and have an impact on others  Experience working in a start-up and/or mid-cap sized company highly desired  Location and Travel This role is remote within the US and requires availability to work US Eastern Time Zone. Occasional travel may be required to the Yardley office, conferences, or other events, up to 25% of the time. Savara provides comprehensive benefits including: Highly competitive medical, dental, and vision coverage Flexible Spending Accounts for health care and dependent care expenses Paid time off and paid holidays, including Dec 24-Jan 1 Paid parental leave 401k with highly competitive match Life, AD&D, STD and LTD insurance coverage Savara’s compensation can include an hourly rate, bonus, and equity. The salary range for this role is $135,000 to $155,000. About Savara: Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Our lead product candidate, MOLBREEVI, is an inhaled recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (autoimmune PAP). MOLBREEVI is delivered via a proprietary investigational eFLOW® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of MOLBREEVI. Our management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. Our goal is to become a leader in rare respiratory disease therapeutics through the development and commercialization of novel, best-in-class medicines that address unmet medical needs in this field. Savara is an equal opportunity employer. MOLBREEVI is the proposed trade name for molgramostim inhalation solution. It is not approved in any indication. MOLBREEVI is a trademark of Savara Inc. #LI-Remote